Monday, December 23, 2024
HomeTagsPARP inhibitor

PARP inhibitor

MOMA Therapeutics Begins Phase 1 Trial for MOMA-313

MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, announced that the first patient has been dosed in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics